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Analysis of human ES cell differentiation
establishes that the dominant isoforms of
the lncRNAs RMST and FIRRE are circular
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Francesco K. Mastrorosa1, Ingrid Ehrmann1, Majlinda Lako1, David J. Elliott1, Mauro Santibanez-Koref1
and Michael S. Jackson1*
Abstract
Background: Circular RNAs (circRNAs) are predominantly derived from protein coding genes, and some can act as
microRNA sponges or transcriptional regulators. Changes in circRNA levels have been identified during human
development which may be functionally important, but lineage-specific analyses are currently lacking. To address this, we
performed RNAseq analysis of human embryonic stem (ES) cells differentiated for 90 days towards 3D laminated retina.
Results: A transcriptome-wide increase in circRNA expression, size, and exon count was observed, with circRNA levels
reaching a plateau by day 45. Parallel statistical analyses, controlling for sample and locus specific effects, identified 239
circRNAs with expression changes distinct from the transcriptome-wide pattern, but these all also increased in abundance
over time. Surprisingly, circRNAs derived from long non-coding RNAs (lncRNAs) were found to account for a significantly
larger proportion of transcripts from their loci of origin than circRNAs from coding genes. The most abundant, circRMST:
E12-E6, showed a > 100X increase during differentiation accompanied by an isoform switch, and accounts for > 99% of
RMST transcripts in many adult tissues. The second most abundant, circFIRRE:E10-E5, accounts for > 98% of FIRRE
transcripts in differentiating human ES cells, and is one of 39 FIRRE circRNAs, many of which include multiple
unannotated exons.
Conclusions: Our results suggest that during human ES cell differentiation, changes in circRNA levels are primarily
globally controlled. They also suggest that RMST and FIRRE, genes with established roles in neurogenesis and topological
organisation of chromosomal domains respectively, are processed as circular lncRNAs with only minor linear species.
Background
Circular RNAs (circRNAs) are a numerically abundant
RNA species, generally expressed at low levels relative to
mRNAs [1, 2], which can be defined in silico by the pres-
ence of “shuffled” or “back-spliced” exons in an order in-
consistent with genomic DNA. Rare trans-splicing events
between different pre-mRNA molecules can, however, also
generate rearranged exon junctions [3, 4], meaning that
additional evidence such as resistance to RNase R [5], mi-
gration assays [6], or comparison of read depth inside and
outside of the circRNA [7], is required to confirm circular-
ity in individual cases.
CircRNA biogenesis can be promoted by intronic hom-
ology [5, 8, 9], and knock-down of the dsRNA editing en-
zyme ADAR1 [10, 11], or the RNA helicase DHX9 which
can interact with ADAR1 [12], leads to upregulation of
circRNA expression. Cassette exons have been shown to
be over-represented within circRNAs [13], and a combin-
ation of RNAi screens and specific gene analyses have
established that RNA binding proteins including MBL
[14], QKI [15], and heterogeneous nuclear ribonuncleo-
proteins (hnRNPs) [16] promote formation of some cir-
cRNAs. Furthermore, both depletion of pre-mRNA
splicing factors, and transcript termination read-through,
can increase circRNA levels relative to linear [17].
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The vast majority of circRNAs are derived from protein
coding genes and have no known function [18, 19], but
there is evidence that some can act as micro RNA sponges
[20–23], some can enhance the activity of their own pro-
moters [24], some can contribute to the proteome [25–27],
and a growing number are being associated with disease
(reviewed in [28]). For example, a circRNA isoform of the
long non-coding RNA (lncRNA) ANRIL1 has been impli-
cated in atheroprotection [29, 30], while circRNAs created
by an oncogenic fusion have been reported to influence
tumour progression [31].
Given the evidence for biological impact, changes in cir-
cRNA expression are of interest as they could be indica-
tive of function. CircRNAs are almost always co-expressed
with linear transcripts from the same loci [32], and their
expression has been shown to increase relative to linear
RNA during development [11], proliferation [33], and age-
ing [34, 35]. Global increases over time have been ob-
served in heart and lung, but are most pronounced in
neural tissues [11, 34–37]. Moreover, divergent expression
patterns of linear and circular RNAs from the same loci
have been highlighted in multiple neuronal tissues, at a
variety of developmental stages and in different species
[11, 36, 38], providing circumstantial evidence for inde-
pendent regulation of linear and circular isoforms.
The circRNA population of human ES cells during early
differentiation has also been investigated and CircBirc6
[39], together with a linear trans-spliced RNA derived
from the lncRNA RMST (tsRMST [40]), have been re-
ported to play roles in maintenance of pluripotency [40].
However, analyses of long-term differentiation series, to
investigate changes in circRNA abundance within defined
cell lineages, are currently lacking. Here, we have differen-
tiated human ES cells (H9 line) towards 3D laminated ret-
ina using an established 90 day protocol [41, 42], and have
performed total RNAseq to a depth of > 100 million reads
in 3 biological replicates at 3 time-points (0, 45, 90 days).
Global circRNA levels increased dramatically between day
0 and day 45, and circRNA size and exon number also in-
creased. When we controlled both for this transcriptome-
wide increase, and for locus specific changes in total ex-
pression, we identified 239 circRNAs with significantly al-
tered expression levels between time-points. All also
increased in abundance, consistent with circRNA levels
being controlled globally during differentiation. Surpris-
ingly, however, we identified a significant difference in cir-
cRNA levels between coding and non-coding genes, and
found evidence that two lncRNAs with known functions
in early development, RMST and FIRRE, may warrant
classification as circular lncRNAs in human.
Results
To identify circRNAs potentially involved in the develop-
ment of a defined cell lineage, we differentiated triplicate
human ES cell cultures towards a retinal phenotype [41],
with and without the presence of IGF-1 which has been
reported to enhance retinal differentiation [42]. Embryoid
bodies (EBs) with retinal features developed in all repli-
cates (see Methods), and immunostained cryosections of
organoids at day 90 confirmed the presence of laminar
retinal tissue organisation, with Pax6 positive retinal pro-
genitors, HuC/D positive retinal ganglion cells, and Crx/
Recoverin positive photoreceptors (Fig. 1).
To assess gene expression, total RNA was extracted at
day 0, 45 and 90, ribodepleted, and sequenced to a depth
of over 100 million reads per replicate (see Methods and
Additional file 1). Consistent with the phenotypic changes
observed, gene ontologies relevant to the eye were signifi-
cantly over-represented among genes differentially
expressed between time points (e.g. phototransduction,
sensory perception of light stimulus, and structural con-
stituent of the eye lens, Additional file 2), while known
pluripotency genes and eye field markers were downregu-
lated and upregulated respectively (Additional file 3:
Figure S1). In contrast, the impact of IGF-1 upon tran-
scription was very specific, with 30 genes differentially
expressed between treated and untreated samples, many
of which are implicated in development or neuronal func-
tion (See Additional file 2). Of particular interest are
WNT2B and FGF16, as inhibition of Wnt signalling has
been shown to enhance forebrain patterning [41] and FGF
signalling modulates retinal progenitor proliferation and
fate [43], and IRS4 and LIN28A, both of which are already
known to be involved in IGF-1 signalling [44, 45]. Thus,
while few genes are affected by IGF-1, they include logical
candidates for involvement in the reported impact of this
mitogen [42].
circRNA levels increase dramatically during the first
45 days of differentiation
We used PTESFinder [46], a software tool with high sensi-
tivity and specificity [47], to quantify all circRNA (back-
splice) and canonical junctions at all time-points (see
Methods and Fig. 2). A total of 58,528 distinct circRNAs
were identified, the majority of which were also found
using other circRNA identification tools ([8, 20, 34], see
Additional file 3: Figure S2). Hierarchical clustering using
normalised gene expression values (Fig. 2a), circRNA
junction counts (Fig. 2b), or canonical exon junction
counts (not shown), all identified day 0 samples as a dis-
tinct group. This distinction is clear from a heat map of
genes differentially expressed between time-points and
treatments (Additional file 3: Figure S3), and is con-
sistent with the limited expression signature associ-
ated with IGF-1 treatment. The limited impact on
circRNA levels is also consistent with Enuka et al.
[32] who found that stimulation of mammary cells by
EGF did not affect circRNA abundance.
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Relative to canonical junctions, circRNA junctions were
present at low levels at all time-points (Fig. 2c-d), but they
showed a significant ~ 4-5X increase between day 0 and
day 45 (p = 0.0044 Wilcoxon rank sum test, Fig. 2c).
Significant increases were also observed in the physical
distance between circRNA donor and acceptor exons
(genomic span), and the number of exons circRNAs con-
tain (Fig. 2e, both p < 9.2e-39 Wilcoxon rank sum test).
Approximately 6% of the circRNAs identified were
found only in undifferentiated samples (day 0, Fig. 2f )
, compared to over 70% found only in differentiated
samples (Day 45/90), and detailed analysis found no
evidence of abundant circRNAs specific to undifferen-
tiated ES cells (Additional file 3: Figure S4).
To investigate the increase in circRNAs in detail, junction
count distributions from all genes were then examined at
day 0 and day 45. This established that the number of both
circRNAs and circRNA junctions increased more dramatic-
ally between day 0 and day 45 (Fig. 3a) than the number of
independent transcripts and canonical junctions (Fig. 3b).
To assess these changes at the gene level, ratios of normal-
ised circRNA junction counts at day 45 relative to day 0 for
each gene were plotted against the corresponding ratios for
canonical junctions (Fig. 3c): Both circRNA and canonical
junctions increased between day 0 and day 45, but the in-
crease in circRNA junctions was more pronounced (me-
dian increase ~8X, log2 = 3). In contrast, there was little
change in circRNA or canonical junction abundance be-
tween days 45 and 90, with circRNA levels remaining par-
ticularly stable (Fig. 3d). Despite this, ratios were correlated
in both comparisons, consistent with circRNA levels at
each locus being linked to total transcription.
As Muscleblind [14] and QKI [15] RNA binding proteins
can promote circularisation, their expression was investi-
gated. Although QKI remained unchanged (data not
shown), 2 out of the 3 human Muscleblind genes showed a
significant increase by day 45 (Fig. 3e and Additional file 3:
Figure S1). Furthermore, the levels of ADAR1 [10, 11] and
DHX9 [12], which can reduce circRNA levels, decreased
significantly (Fig. 3f-g), consistent with involvement in the
Fig. 1 Neuronal differentiation in retinal organoids. a-b Retinal organoids on day 23 of differentiation displaying (a) phase bright neural retinal
tissue and (b) retinal pigmented epithelium (RPE). c-f Immunostained cryosections of retinal organoids on day 90 of differentiation counterstained with
Hoechst demonstrating the laminar organisation of retinal tissue and presence of (c) Pax6+ retinal progenitors, inner retinal neurons and (d) HuC/D+
retinal ganglion cells at the basal aspect, and (e, f) outer retinal phenotypes including Crx + and recoverin+ photoreceptors towards the apical surface.
GCL = ganglion cell layer, ONL = outer nuclear layer. Scale bars; a, b = 200 μm; c, d = 50 μm; e, f = 20 μm
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observed circRNA upregulation. A small but significant
excess of RNA editing sites (targeted by ADAR1) was
also observed within 1000 bp of circRNA junctions
found only in differentiated time-points, when com-
pared to junctions found only at day 0 (p = 0.0329 Wil-
coxon rank sum test, Fig. 3h).
CircRNA expression change is defined by global
upregulation and locus specific transcription levels
The upregulation of circRNAs prior to day 45, and their
subsequent relative stability, suggests that their abundance is
controlled at the transcriptome level during human ES cell
differentiation. To identify circRNAs showing differential
Fig. 2 circRNA expression increases upon differentiation. a Phylogram based on expression levels of all genes. b Phylogram based on circRNA
(back-splice) junction counts. Both generated using hierarchical clustering of Euclidian distances. c-d Box and whisker plots of circRNA and canonical
junction counts from all genes which generate circRNAs. CircRNAs increase from ~ 0.3 to 1-2% of all junctions between day 0 and 45. e Box and
whisker plots showing (left) genomic span of circRNAs in day 0 (n = 13,146) versus differentiated (day 45 and 90, n = 42,521) untreated
samples, and (right) exon counts of circRNAs in day 0 only (n = 2790) versus differentiated only (n = 32,084) untreated samples. For exon
count calculations, all GENCODE exons between circRNA donor and acceptor exons were included. For all box-plots, medians and upper
and lower quartiles are shown, with outliers as solid circles. f Venn diagram showing distribution of circRNA junctions identified in untreated day 0
samples, relative to differentiated samples (days 45 and 90). Comparable results were obtained with IGF-1 treated samples
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Fig. 3 circRNA expression reaches a plateau by day 45. a-b Histograms comparing junction counts per transcript in day 0 and day 45. c-d Comparison of
changes in back-splice and canonical junction count frequencies between time points. Junction counts were normalised to total read counts at each time-
point. Distributions are shown on both axes, together with correlation coefficients and associated p-values. e-g Expression of genes implicated in circRNA
biogenesis in untreated samples. Associated p-values from t-tests comparing means in day 0 versus day 45/90 are shown. h Box and whisker plot
comparing frequencies of RNA editing sites found within 1000 bp windows flanking circRNA junctions in undifferentiated (day 0) or differentiated
(day 45 and day 90) samples only, with associated p-value (Wilcoxon rank-sum test)
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expression (DE) patterns, independent both of the glo-
bal increase and of changes in total expression at their
loci of origin, we performed two sets of pairwise com-
parisons between time-points: One (sample-level DE
analysis) controlled for differences in library size and
total circRNA levels between samples, the other (locus-
level DE analysis) controlled for locus specific changes
in total gene expression. Fisher exact tests were first
performed, using junction counts summed across repli-
cates, to identify candidate differentially expressed (DE)
circRNAs. Then, to mitigate against sample heterogen-
eity, read counts of these candidate DE circRNAs in
each replicate were re-analysed using two-tailed t-tests
(see methods and Additional file 3: Figure S5).
In pairwise comparisons between the day 45 and day 90
samples (rows 5-8 Table 1) between 1 and 256 DE cir-
cRNAs were identified using Fisher’s exact tests, but only
1 was significant in either of the subsequent t-tests. In
contrast, over 2500 transcripts were identified in each
pairwise comparison between day 0 samples and later
time-points, and 46-496 were significant in the subse-
quent t-tests (rows 1-4 Table 1). However, only 239 (~ 0.
6% of all circRNAs analysed) gave 1 or more significant
results in both analyses (Table 1 and Additional file 4). Ex-
pression heat maps illustrate that circRNA junction levels
of all 239 increase upon differentiation (Fig. 4a), with
more modest changes in canonical junction counts (Fig.
4b). Thus, these circRNAs differ from the broader popula-
tion only in the magnitude/consistency of expression
change, not direction. Gene Ontology analysis did identify
enrichment of some molecular processes and biological
functions among genes from which these circRNAs are
generated (Additional file 5), but none are specifically rele-
vant to differentiation or neuronal/retinal development. In
an effort to increase power, this analysis was repeated with
day 45 and day 90 samples combined. As expected, this
produced a larger number of DE transcripts (> 2000), but
the direction of change in circRNA levels remained uni-
form (Additional file 3: Figure S6), providing no evidence
for regulation of specific circRNAs independent of the
global upregulation observed prior to day 45.
Non-coding circRNA producing genes have higher
circular/linear ratios than coding genes
The vast majority of the 239 significant DE circRNAs
have been identified previously and are derived from
coding genes (Additional file 3: Figure S4). However, the
most abundant is from RMST, a lncRNA known to be
involved in the regulation of neural stem cell fate [48].
As the functional relationship between linear and circu-
lar transcripts from coding and non-coding loci will be
different, we analysed the relationship between circRNA
and canonical junction frequency with respect to coding
potential (Fig. 4c-d). This established that circRNAs
from non-coding genes make up a higher proportion of
the total transcripts from their loci of origin than cir-
cRNAs from coding genes (p < 1 × 10− 5 Wilcoxon rank-
sum test), with a mean circular to linear junction ratio
of 0.25 (IQR 0.18) compared to 0.04 (IQR 0.024) for
coding genes, despite non-coding genes being generally
expressed at lower levels. Interestingly, the 2nd most
abundant non-coding circRNA was from the lncRNA
FIRRE, implicated in both adipogenesis in mouse [49]
and chromosomal nuclear localisation [50, 51], with
anti-sense RNAs of unknown function also having a high
proportion of circRNA junctions. Because of the known
involvement of both RMST and FIRRE in developmental
processes, we analysed read depth and splice junction
frequency in these two genes in detail.
CircRMST:E12-E6 can account for > 99% of RMST
transcription, and upregulation is consistent with a
promoter change
RMST read and circRNA junction counts were consist-
ent between replicates at each time-point, and represen-
tative data from day 0 and 45 are shown in Fig. 5a. All
exons corresponding to annotated isoform uc001tez.1
(grey) increased > 30 fold in abundance between these
Table 1 Numbers of DE transcripts identified in pairwise time-point analyses, controlling for transcriptome wide changes in circRNA
levels and locus specific changes in total expression
Comparison Locus-level tests Sample-level tests Identified by
both t-testsFisher t Fisher t
day 0 v day 45 4207 63 6411 60 8
day 0 v day 90 2671 80 4577 46 12
day 0 v day 45 IGF-1 2965 496 4395 496 197
day 0 v day 90 IGF-1 2786 126 4362 148 29
day 45 v day 45 IGF-1 60 0 256 0 0
day 45 v day 90 121 0 208 0 0
day45 IGF-1 v day 90 IGF-1 10 1 56 0 0
day 90 v day 90 IGF-1 1 0 15 0 0
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time-points, but there is an equivalent increase in a
back-splice junction which spans all exons in this
transcript. This is consistent with a single abundant cir-
cRNA (circRMST:E12-E6, red box Fig. 5a and see
Additional file 3: Figure S7). Strikingly, when junction
counts across all time-points were analysed (Fig. 5b),
only junctions internal to E6 and E12 (so expected to be
within the circRNA) exceeded 150 counts at any time
point, and most exceeded 3000 at days 45 and 90. An
additional 18 low abundance RMST circRNAs were also
identified, collectively encompassing all but the terminal
annotated exons (Fig. 5b). Furthermore, exon junctions
which both involve the main circRNA splice acceptor
(E6) and could potentially be within linear RNAs (E5-E6
and E5B-E6), were at frequencies < 0.5% of E12-E6 at
later time-points (e.g. 24 and 17 v 5425 at day 45).
To identify potential sites of transcript initiation, exons
5′ to the main circRNA were investigated (Fig. 5c), and
uncovered both a high frequency of intron retention be-
tween exons 1 and 2 of uc001tey1 (defined here as E5A
and E5B, blue box), and a reduction in reads mapping to
this region by day 45. Over the same period there was an
increase in reads and splice-junctions involving E4 and E5
(green box), indicating a change in isoform structure over
Fig. 4 Expression increase of DE genes and abundance with respect to coding capacity. a-b Expression heat maps showing relative frequency of
untreated sample junction counts from 239 DE transcripts identified in both sample-level and locus-level t-tests (see methods). c Total canonical
junctions versus total circRNA junctions in all circRNA producing coding genes (summed across all samples). The 5 genes with the highest circRNA counts
are indicated. d Total canonical junctions versus circRNA junctions in all circRNA producing non-coding genes (summed across all samples). The 10 genes
with the highest circRNA counts are indicated. Total numbers of canonical and circRNA junctions in untreated samples at each time-point are also shown,
and confirm that the increase in junction counts between days 0 and 45 affects circRNAs from both coding and non-coding genes
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Fig. 5 (See legend on next page.)
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time. These exons lie within a regions defined by EN-
CODE/Broad chromatin state segmentation [52] as a weak
promoter (light red) within the human H1 ES cell line
(Fig. 5c). In contrast, transcription immediately upstream
and downstream of the E6-E12 region, which span
miRNA precursors and could potentially be involved in
generation of the circRNA, showed no consistent change
(Fig. 5c middle and right hand panels).
To confirm changes in circRNA levels, and investigate
the putative change in isoform levels, we used qPCR to
assay splice junctions at days 0 and 45, and at an intermedi-
ate time-point (day 30) from the same differentiation series.
Overall, the correlation between RNAseq junction counts
and qPCR data was 0.93 (Additional file 3: Figure S8) and
results are shown in Fig. 5d. A ~ 100 fold induction of E5-
E6 (7-8 Ct) was observed between day 0 and 30, together
with a similar increase in the E5-E5B junction by day 45
(both p < 0.001), the latter establishing that isoforms
ENST00000538559.6 and uc001tey1 are not independent.
A modest drop in E5B-E6 expression was also observed
(p < 0.01 by day 45). The E12-E6 circRNA junction, present
at similar levels to E5B-E6 at day 0, also increased > 100
fold by day 30 (p > 0.001). However, there was little change
in the downstream canonical E12-E13 junction. The induc-
tion of both the E5A containing isoform, and the E12-E6
circRNA, is clear when the data is displayed relative to E12-
E13 (Fig. 5e). In silico analysis of RNAseq data from human
fetal and embryonic eye tissue (Mellough et al. in prepar-
ation) also established that the E12-E6 circRNA is the most
abundant RMST isoform during differentiation in vivo
(Additional file 3: Figure S9).
The lncRNA FIRRE is downregulated, and upon
differentiation its major transcripts are circular
FIRRE expression at day 0 was consistent between repli-
cates, and exons with the highest RNAseq read counts (E5
to E10) were also bound by an abundant back-splice junc-
tion (Fig. 6a and see Additional file 3: Figure S7), indica-
tive of a single dominant circRNA. Although expression
fell in all replicates between day 0 and day 45, heterogen-
eity was observed, with replicate 1 showing a pronounced
drop in expression of all exons (Fig. 6a). This is likely to
reflect differences in activity of the single promoter region
inferred from ENCODE data (Fig. 6a). In total, 20 FIRRE
circRNAs were identified, ranging in abundance over 3 or-
ders of magnitude (Fig. 6b) and encompassing all but 3
annotated exons (E1, E2, E13). All exon junction counts
(Fig. 6b) were consistent with the general reduction in
FIRRE expression between day 0 and 45. Critically, junc-
tion counts involving exons external to circRNAs (E1 and
E2) fell more dramatically than others: Only the E10-E5
circRNA junction, and canonical junctions internal to
these exons, exceeded 150 counts at days 45 and 90
(Fig. 6b). By day 45 the E10-E5 junction count (362)
was ~ 10 fold higher than the E1-E2 junction count (32),
and > 50 fold higher than any counts from junctions which
could both involve the main circRNA acceptor exon
(E5) and be within linear RNAs (E2-E5, 4; E3-E5, 2;
E4-E5, 0). This suggests that in differentiating H9 ES
cells, > 98% of reads from the abundant central exons
are from circular RNAs.
The read distributions also suggested that FIRRE tran-
scripts may contain additional exons which are either un-
annotated, or annotated within alternative transcripts
(grey in Fig. 6b). We investigated these using a combin-
ation of annotation-free exon junction mapping and
amplicon sequencing of RT-PCR products (see Methods).
This both confirmed the existence of the rearranged tran-
script structures inferred from RNAseq data, and estab-
lished that exons E5A, E5B, E6A, and the minor exon
E10A and E10C, are integrated within multiple circRNAs
up to > 1 kb in length (Additional file 3: Figure S10 and
Additional file 6). Of the annotated FIRRE exons, only E1,
E2, E4 and E13 were not identified within circRNAs by
amplicon sequencing. This analysis also ruled out the ex-
istence of FIRRE transcripts containing upstream linear
exons (e.g. E1, E2) spliced directly to unannotated exons
downstream of E5 (Additional file 7), and identified a
(See figure on previous page.)
Fig. 5 RMST is a circRNA in differentiated H9 cells. a Modified UCSC browser representation of mapped read count (black) and back-splice
junction count (blue) at the RMST locus in untreated replicate 1 at day 0 and day 45. Back-splice reads span a single junction and only
the donor and acceptor exons are indicated. Scales are different in the two time-points to allow visualisation of both. GENCODE (green)
and Refseq (purple and grey) annotations are shown, together with genomic scale. Exons within circRMST:E12-E6 are enclosed by a red
box, upstream exons highly expressed at day 0 are enclosed by a blue box. b Schematic of RMST exon structure, showing circRNA junction counts
(above exons) and canonical counts (below exons) summed across untreated replicates for all time-points (0/45/90). Counts were calculated for all
exon combinations within each annotated transcript. Numbers are only shown for junctions with 10 or more supporting reads at 1 or more time-
points. Exons specific to a single annotated transcript are colour coded (as in a). Exons present in multiple annotated transcripts are shown in grey.
Exons are numbered relative to the longest ENCODE annotation ENST00000538559.6 (ENST~ 559.6). Annotated (red) and inferred (orange) transcription
start and stop sites are also shown. Data from IGF-1 treated samples are comparable. c Adapted UCSC screen-shots showing changes in expression at
exons of uc001tey.1 and ENST00000538559.6 upstream of E6 (left panel) and miRNA precursors flanking the E12-E6 circRNA (middle and right panels)
in all untreated replicates. ENCODE/Broad chromatin state segmentation [52] within the H1 ES cell line is also shown (H1): Light red/bright red/purple
= weak/active/poised promoter, light/dark green =weak/elongation transcription, orange/yellow = strong/weak enhancer). Scale is capped at 150 to
allow direct comparison between time-points. d-e qPCR confirmation of increase in RMST circRNA and E5-E5B junctions. d. Mean ΔCt values from 3
biological replicates assayed at day 0, 30 and 45 are shown (+/− S.E.M). e ΔΔCt values relative to E12-E13. p-values *p < 0.05, **p < 0.01, ***p < 0.001
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Fig. 6 (See legend on next page.)
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further 19 circRNA junctions and minor unannotated
exons distal of E10 (Additional file 3: Figure S10).
Interestingly, a dot-matrix of internal sequence repeti-
tion within FIRRE (Additional file 3: Figure S11) also
established that the E5-E10 region contains the ma-
jority of the DCC repeats known to function as nu-
clear localisation signals [50, 53].
We used qPCR to validate the expression levels of E10-
E5 and upstream exon junctions within RNAs isolated at
days 0 and 45, together with an intermediate time-point,
day 30 (Fig. 6). The correlation between RNAseq-derived
junction counts and qPCR data across all FIRRE assays was
0.75, lower than for RMST (Additional file 3: Figure S8).
This is likely due to the impact of repetitive sequence ([53]
and Additional file 3: Figure S11) on both read mapping
and PCR amplification. Despite this, the relative expression
of all junctions at day 0 were consistent with the RNAseq
data (Fig. 6d). We did observe an increase in E10-E5 ex-
pression by day 30, a time-point not assayed by sequencing,
but all other junctions decreased in abundance. The rela-
tively low expression level of all FIRRE exons in replicate A
by day 45 (Fig. 6a) resulted in large standard errors of ex-
pression estimates at this time-point. However, relative ex-
pression levels of junctions remained consistent within
replicates at each time-point, and the fall in E1-E2 and E2-
E3 relative to E10-E5 observed in the RNAseq data was
both confirmed, and found to be significant (~ 16-32X re-
duction, Fig. 6e). In silico analysis of RNA seq data from
human fetal and embryonic eye tissue also established that
the E10-E5 circRNA is the most abundant FIRRE isoform
during differentiation in vivo (Additional file 3: Figure S9).
RMST E12-E6 accounts for > 99% of adult neural RMST
expression
Having established that two functionally important
lncRNAs almost exclusively generate circular isoforms
during ES differentiation, we investigated their abun-
dance in adult tissues (Fig. 7). In all neural tissues ana-
lysed as well as heart, the RMST E12-E6 circRNA
junction was detected 7-8 cycles earlier than either of
the linked upstream canonical junctions assayed (E5-E6,
E5B-E6), indicating that it is also > 100 fold more abun-
dant in these tissues (Fig. 7a). Read and back-splice dis-
tributions within independent publicly available total
RNAseq data from adult brain [54] were also consistent
with this (Additional file 3: Figure S12). In tissues such
as lung and kidney the circRNA was ~ 15-50X more
abundant, while in liver the linear transcripts could not
be detected. In contrast, all FIRRE structures are present
at much lower levels in the adult tissues analysed relative
to ES cells (Fig. 7b), consistent with previous analyses
[50]. Although all junctions were detected at low levels,
E1-E2 was ~ 10X more abundant than other junctions in
spinal cord, and the E10-E5 junction was very low in all tis-
sues, indicating no circRNA enrichment. In silico analysis
of independent publicly available RNAseq datasets also
confirmed the low expression of all FIRRE exons in the
adult tissues analysed here, as well as skin, breast, muscle,
bladder, prostate, ovary, and colon ([54], data not shown).
RMST and FIRRE exons external to circRNAs are sensitive
to RNase R
To confirm that transcripts from both genes are circu-
lar in ES cells, we tested the prediction that circRNA
specific exon junctions would be resistant to RNase R,
using independent day 0 RNA isolations from the H9
cell line (Fig. 7c). As anticipated, RNase R digestion
reduced levels of linear housekeeping genes ~ 100-500
fold (~ 7-9 cycles, left panel). In contrast, RMST E12-
E6 and FIRRE E10-E5, together with FIRRE E10-E11
(which is present within 8 circRNAs), were enriched
~ 30-60 fold relative to linear housekeeping controls,
significantly more than other junctions (p < 0.01 all
comparisons). This is similar to the enrichment seen
with a control circRNA (SMARCA5 E16-E15 [7, 15]).
However, the terminal exons assayed, which are not
associated with any circRNAs (RMST E12-E13 and
FIRRE E1-E2), showed no enrichment, confirming
their linearity. Other proximal exons assayed either
showed limited enrichment (2-4 fold RMST E5-E6,
(See figure on previous page.)
Fig. 6 FIRRE is downregulated, and its major transcripts are circular in differentiated cells. a Modified UCSC browser representation of mapped
read count coverage (black) and back-splice junction count (blue) at the FIRRE locus in untreated replicate 1 at day 0 (top), shown above the
mapped read data from all untreated replicates at days 45 and 90. Back-splice reads span a single junction and only the donor and acceptor
exons are indicated. GENCODE (green) and RefSeq (purple) annotations are also shown, together with a genomic scale. ENCODE/Broad chromatin
state segmentation [52] within the H1 ES cell line is also shown: Light red/bright red/purple = weak/active/poised promoter, light/dark green =
weak/elongation transcription, orange/yellow = strong/weak enhancer, grey = heterochromatin low signal, blue = insulator. b Schematic of FIRRE
exon structure, showing circRNA junctions and counts (above exons) and canonical junctions and counts (below exons), summed across un-
treated replicates for all time-points (0/45/90). Additional exons not present within the GENCODE FIRRE annotation are shown in grey (asterisked)
and numbered A, B etc. with respect to ENCODE annotation. Only junctions involving annotated FIRRE exons are shown, and numbers are only
given for junctions with 10 or more supporting reads in 1 or more time-points. c Modified UCSC browser image showing position and relative
abundance of additional exons not in ENCODE annotation. The scale is split at 150 to facilitate visualisation of rare exons (see Additional file 3:
Figure S4). d-e qPCR validation of expression changes of circFIRRE:E10-E5 and upstream junctions. d. Mean ΔCt values from 3 biological replicates
assayed at day 0, 30 and 45 are shown (+/− S.E.M). e. ΔΔCt values relative to to E10-E5. *p < 0.05, **p < 0.01
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Fig. 7 Tissue distribution and RNase R resistance of RMST and FIRRE junctions. a RMST junctions in adult tissue. b FIRRE junctions in adult tissue.
Mean ΔCt values of 3 technical replicates are shown (+/− S.E.M). c RNase R sensitivity of RMST and FIRRE junctions. Left panel; –Ct values of 3
housekeeping genes in digested and mock reactions. Right panel; -ΔΔCt values of RNase R digested relative to undigested (see methods). A
control linear/circRNA transcript pair (SMARCA5) is also shown. Means from 3 biological replicates are shown +/− S.E.M, except for FIRRE E2-E5
where only technical replicates were available. *p < 0.05, **p < 0.01, ***p < 0.001. d Replicate Northern blots of day 0 ES (E) and adult brain (B)
RNAs, digested with RNase R (D) or undigested (U) and hybridised with i. SMARCA5 probe internal to circRNA (E15-E16), ii. SMARCA5 probe external to
circRNA (E10-E13), iii. RMST probe internal to main circRNA (E6-E9), iv. RMST probe external to main circRNA (retained intron 5A-E5B), v. GAPDH probe
(E3-E6). RNase R resistant transcripts are highlighted with asterisks, and approximate position of human rRNAs are shown
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E5B-E6), or no enrichment (FIRRE E2-E5), suggesting
they are also primarily within linear RNAs.
Finally, RNase R resistance of RMST E12-E6 was also
confirmed by Northern blotting of RNA from day 0 ES
cells and adult brain (Fig. 7d). A control probe internal to
the circRNA from SMARCA5 (E16-E15) confirmed effect-
ive RNase R digestion, as it identified a small RNase R re-
sistant transcript abundant only in brain (Fig. 7d-i) which
was not identified by a SMARCA5 probe external to the
circRNA (Fig. 7d-ii). This is consistent with RNAseq data
(Additional file 3: Figure S12) and qPCR data (above). The
RMST probe internal to the main E12-E6 circRNA
(Fig. 7d-iii) identified a single RNase R resistant tran-
script as the dominant isoform in adult brain, also con-
sistent with RNAseq data (Additional file 3: Figure S12)
and qPCR data (above). Furthermore, this transcript was
less abundant than other, longer, RMST transcript in ES
cells, and was not identified by the RMST probe external
to the E12-E6 circRNA (Fig. 7d-iv). The intensity of hy-
bridisation to this transcript indicated some loss of mater-
ial during RNase R digestion. However, loss was also
observed with the SMARCA5 circRNA control. These re-
sults provide additional evidence that RMST E12-E6 cir-
cRNA is the dominant isoform in adult brain. They also
establish the presence of linear RMST isoforms over 5 kb
in length within H9 ES cells, much longer than current
annotations for this gene (~ 1.0-2.6 kb).
Discussion
We have performed deep sequencing of a human ES cell
retinal differentiation series to investigate changes in cir-
cRNA expression in a defined cell lineage, and to iden-
tify those of potential functional importance. We
observed a striking transcriptome-wide increase in cir-
cRNA abundance specifically within the first 45 days,
consistent with circRNA levels being under global con-
trol during differentiation. These results have parallels
with temporal increases observed in previous analyses of
tissues from a variety of species [32, 34, 37, 55], but the
observation here of rapid circRNA increase upon differ-
entiation, followed by relative stasis, is novel.
The most abundant circRNA we observed, and the one
which showed the most significant change in expression
over time, was from the lncRNA RMST, previously impli-
cated in neuronal differentiation [48]. Surprisingly, we es-
tablish that > 99% of the transcriptional output from
RMST in differentiating human ES cells, and a variety of
adult tissues, is accounted for by this circRNA. This pro-
vides a simple explanation for the very weak signals ob-
tained in Northern blots of PolyA+ RNA from brain
during the original characterisation of this gene [56]. The
RMST:E12-E6 structure was first described as an ES cell-
specific trans-spliced transcript (tsRMST) and reported to
play a role in maintenance of pluripotency [40]. However,
it has since been shown to be both circular and abundant
in differentiating and adult tissues ([11, 37], this study). It
was identified as one of several hundred circRNAs
expressed at > 50% of the level of associated linear iso-
forms in embryonic neuronal tissues [37]. In addition, its
murine orthologue is abundant in mouse brain, RNase R
resistant, and enriched in synaptoneurosomes [11]. Critic-
ally, the expression differential established here between
circRMST:E12-E6 and flanking exons suggests that the
RMST isoform in differentiated cells warrants classifica-
tion as a circular lncRNA, and that linear transcripts could
represent by-products or unprocessed precursors. Our re-
sults also suggest that the circular isoform present in dif-
ferentiating cells and adult tissues, and linear isoforms
present in ES cells, are driven by distinct promoters.
We have also established that FIRRE is predominantly
a circular lncRNA during human ES cell differentiation
when it is expressed at high levels, and that the major
circular isoform can account for > 98% of FIRRE tran-
scription. This provides a simple explanation for the re-
ported stability of mature FIRRE transcripts relative to
pre-mRNAs [50], and for the larger changes in FIRRE
expression observed in total RNA relative to oligodT
enriched templates [51]. We have identified a total of 39
FIRRE circRNAs whose abundance spans 3 orders of
magnitude, and confirmed the integration of novel unan-
notated FIRRE exons into circular transcripts. While the
complexity of this locus has been noted [50], it is clear
from our in silico analysis and amplicon sequencing that
the structure and transcriptional output of this gene re-
mains to be fully resolved. Furthermore, for both genes,
sequence motifs and RNA binding proteins involved in
circularisation, and the factors which control promoter
activity and isoform changes, remain to be defined.
The huge differential in abundance of circular and linear
exons we observed in differentiated time-points (average
of >100X for RMST and > 30X for FIRRE) is presumed to
be due to stability of circular forms and degradation of
back-splice by-products. On an evolutionary timescale cir-
cularisation may provide a route through which the level
of a lncRNA can be dramatically increased, due to the re-
duced degradation of circular forms, without altering pro-
moter activity. It follows that subtle changes in the activity
of promoters driving both genes could have profound ef-
fects upon circRNA levels and may, for instance, underpin
the expression heterogeneity observed here for FIRRE at
day 45. Our data also suggest that high sequencing
depths will be required to accurately define the linear
exons and transcription start sites of circular lncRNAs
such as these and, together with the recent discovery
that the archetypal circRNA ciRS-7 (CDR1-AS) is em-
bedded within cryptic exons of a linear lncRNA [57],
highlight the growing need for the integration of cir-
cRNA data within genome-wide annotations.
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A key question to address is whether circularity merely
serves to influence transcript abundance, or whether it can
impact qualitatively upon function. While in vitro over-
expression of both RMST and FIRRE have been shown to
rescue some effects of loss or absence of endogenous gene
expression [40, 48], the linear transcripts used in these ana-
lyses contained exons shown here to be almost exclusively
circular at some time-points. As circularisation will alter se-
quence proximity and relative orientation, it could influ-
ence protein binding or binding partner position within
RNA/protein complexes. Isoform differences could, there-
fore, account for the distinct roles in pluripotency [40] and
neuronal differentiation [48, 58] attributed to RMST. Fur-
thermore, circularity may increase complex stability, some-
thing particularly relevant to FIRRE which is involved in
establishing and maintaining physical interactions between
remote chromatin domains [59].
Our observation that circRNAs from non-coding RNAs
account for a higher proportion of transcriptional output
from their loci of origin than other circRNAs is also of
interest, as the novel circular antisense RNAs we have
identified may represent further circular lncRNAs of func-
tional importance. However, non-coding RNAs are
enriched for interspersed repeats which can promote cir-
cularisation [5, 8, 9], so it is possible that differences in the
local genomic environment will contribute to these ele-
vated circRNA levels.
Conclusions
Finally, although there are a growing number of reports of
functional circRNAs derived from coding genes [22, 60–62],
some of the clearest evidence for circRNA function involves
transcripts from non-coding loci. These include CDR1-AS
and CircPVT1, which act as sponges for miR-7 and let-7 re-
spectively, and have been implicated in zebrafish midbrain
development [20] and cellular senescence [23]. In addition,
CircANRIL has been shown to modulate rRNA maturation
through binding to the 60S rRNA assembly factor PES1
[29]. Current evidence suggests that the two lncRNAs de-
fined here as being circular, function through distinct mech-
anisms: RMST is a transcriptional co-regulator which can
bind to SOX2, hnRNPS2/B1, NANOG, and the PRC2 com-
plex [40, 48], while FIRRE has been implicated in organising
chromosomal domain topology, and tethering the inactive X
chromosome to the periphery of the nucleolus through
interaction with CTCF [50, 51]. Our results therefore also
extend the range of molecular mechanisms through which
circRNAs are known to function.
Methods
Source of human materials used
All tissue RNAs, and the control human DNA, were ob-
tained as purified nucleic acids from Biochain (AMS
Biotechnology).
Differentiation of H9 ESCs
Passage 34-35 of the human embryonic stem cell line
H9 line (obtained from WiCell, agreement number 06-
W097), were expanded and differentiated according to
the protocol outlined in [41], with minor modifications
[42] to generate 3D laminated retina containing the
major retinal cell types including photoreceptors. Cells
were differentiated in triplicate with and without insulin
growth factor 1 (IGF-1) treatment [42]. Upon differenti-
ation, hESCs formed embryoid bodies (EBs) which de-
veloped morphologically distinct phase-bright structures
reminiscent of the evaginating optic vesicle and invagin-
ating optic cup, as previously described [42]. Phase-
bright structures were first observed to develop around
the periphery of differentiating EBs, with optic vesicles
arising as early as day 15 and optic cups developing by
day 45. The retinal identity of these structures was deter-
mined by immunocytochemistry: Retinal organoids were
cryosectioned and reacted against Pax6 (Covance PRB-
278P, 1:200), HuC/D (Invitrogen A21271, 1:100), Crx
(Abnova H00001406-M02, 1:200) and Recoverin (Milli-
pore AB5585, 1:1000) antibodies as previously described
[42]. Images were obtained using a Zeiss Axio Imager.Z1
microscope with ApoTome.2 accessory equipment and
AxioVision or Zen software.
High-throughput RNA sequencing
Cells were harvested at multiple time points without any
physical selection for embryoid bodies, to ensure cells
harvested were representative of the whole population.
RNA was extracted using the RNAeasy micro extraction
kit with DNA elimination columns according to manu-
facturer’s recommendations. RNA was quantified using
the NanoDrop ND-1000 spectrophotometer (Thermo
Scientific), and RNA quality was assessed using the Agi-
lent 2100 Bioanalyser (Agilent Technologies). RIN values
indicated some reduction in RNA quality over time, with
day 0 sample RIN values ranging from 9.8-10, day 45
ranging from 7.6-9.1 and day 90 ranging from 7.1-8.9.
RNAs were ribosome depleted and sequenced by AROS
Applied Biotechnology (Aarhus, Denmark), using the
TruSeq RiboZero Stranded Total RNA LT kit (Illumina)
to generate paired-end 100 bp sequence libraries as de-
scribed previously [7].
Sequence references
Genome and transcriptome FASTA files for human
(HG19) were obtained from the UCSC genome browser
[63]. Aligner-specific index files were built for STAR
(command: STAR —runThreadN 8 —runMode genome-
Generate —genomeFastaFiles $hg19_dir —genomeDir
$output_dir), and Bowtie1 (command: bowtie-build hg19.
fa hg19) and Bowtie2 (bowtie2-build hg19.fa hg19)
aligners.
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Mapping
The quality of sequenced reads was checked with
FASTQC (http://www.bioinformatics.babraham.ac.uk/pro
jects/fastqc/). Sequence reads were first mapped to the
genome using Bowtie2 [64] to derive inner distance met-
rics prior to Tophat [65] runs. Metrics were calculated
using CollectInsertSizeMetrics.jar from Picard (https://
sourceforge.net/projects/picard/). Parameters for Tophat
runs were: —library-type fr-firststrand, —no-coverage-
search, —b2-sensitive, —microexon-search and -× 20. For
alignments to the genome using STAR [66] parameters
used were: —outFilterMultimapNmax 7 and —outFilter-
MismatchNmax 2. Annotation free canonical splice-
junction mapping was performed, where indicated, with
MapSplice 2.0 [67] using default parameters.
circRNA (back-splice) and canonical splice detection
After modifying read ids, PTESFinder v.1 [46] was used to
screen all reads from each sample for back-splice exon
junctions within the GENCODE v19 human reference
transcript set, using the following parameters: JSpan = 8,
PID = 0.85, segment size = 60 and m = 7. Analyses were
guided by supplying FASTA sequences of previously iden-
tified back-splice junctions (n = 40,594). PTESFinder was
also used for annotation-free identification of back-splice
junctions against the HG19 human reference genome se-
quence (modified scripts available on request).
Analysis of RNA editing sites
RNA editing sites were identified in 1000 bp regions
flanking circRNA back-splice junctions by cross-
referencing genomic coordinates of published RNA edit-
ing sites (rnaedit.com [68, 69]) using intersectBed and
closestBed from BEDTools. Data from circRNA generat-
ing genes identified only in day 0 only were then com-
pared to circRNA producing genes identified only in
differentiated cells (day 45 and 90).
Gene expression estimates
HTSeq [70] and Cufflinks [71] were used to quantify
transcripts. Library size normalisation and statistical
tests of differential expression (based on raw counts pro-
duced using HTSeq) were performed using the DESeq2
[72] package in R (https://www.r-project.org). Splice site
expression values were calculated as Junctions per Mil-
lion (JPM) by dividing each junction count by total
counts per sample (canonical + back-splice) and multi-
plying by 10e6. Gene ontology analyses were performed
using the Panther classification system [73].
Visualisation
BigWig files were generated from alignments to the gen-
ome using genomeCoverageBed from BEDtools and bed-
GraphToBigWig from UCSC, and visualised using Galaxy,
a web-based tool for sequence analysis [74]. Distributions
of aligned reads were visually examined on the integrative
genomics viewer [IGV v 2.1.21 [75]] and on the UCSC
genome browser. Dot matrix analyses were performed
using YASS [76] with default parameters. Exon junction
heat maps were generated using junction counts normal-
ised to total read counts per sample, and mean expression
value of each transcript across samples.
Statistical analysis of back-splice abundance
To identity significant changes in circRNA abundance,
two tests for differential expression (DE) were performed
(see Additional file 3: Figure S5):
Sample level DE analysis
To account for differences in library size and transcriptome-
wide changes in circRNA expression levels between pairs of
time points, contingency tables for each circRNA were
constructed consisting of circRNA junction counts in
both time points, versus total junction counts (circular
and canonical) minus the circRNA junction counts for
the circRNA being tested.
Locus level DE analysis
To control for locus specific changes in total gene expression
between time points, contingency tables for each circRNA
were constructed using only junction counts from the locus
of origin. These consisted of circRNA junction counts in
time points A and B, versus canonical junction counts from
all annotated exons from the locus being tested.
For both analyses, Fisher’s exact tests were first per-
formed for each circRNA using contingency tables gen-
erated from summed read counts across replicates. To
control for heterogeneity, t-tests were then performed
on all the significant circRNAs, using read count data
from each replicate normalised against total sample read
count (Sample-level analysis) and against total read
count from each transcript (locus level analysis). A
Benjamini-Hochberg false discovery rate of 0.05 was
used as threshold throughout. Expression heat maps
were generated from circRNA junction counts within
untreated samples following removal of transcripts
present in segmental duplications. Read counts were
subject to sample normalisation relative to total read
count, and transcript normalisation relative to mean
junction count across samples.
Quantitative PCR (qPCR)
cDNA was synthesized using high-capacity cDNA kits
(Applied Biosystem) with random hexamers according
to manufacturers recommended protocols. Quantitative
PCR experiments were performed using Taqman master
mix (Life Technologies). Primers and probe sequences
are given in Additional file 8. Transcript expression was
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normalized using the ΔCt method relative to the geo-
metric mean of 3 housekeeping genes (GAPDH, PPIA
and GUSB) analyzed using TaqMan gene expression as-
says (Applied Biosystems) as described previously [7].
Significance of expression differences was assessed using
2 tailed t-tests.
RNase R digestion
For qPCR, one microgram of RNA was added to 1 μl of
10× RNase R buffer and 20 units of RNase R (Epicentre), or
zero units for mock treatment, in a 10 μl reaction volume.
Tubes were then incubated at 37 °C for 30 min. For North-
erns, one unit of enzyme was used per μg of RNA, and re-
actions were stopped by incubation at 70 °C for 15 min.
Northern analysis
Replicate sample sets consisting of 6 μg of RNAse R
digested and undigested total RNAs from Day 0 H9 ES
cells and adult brain were loaded on to a 0.9% formalde-
hyde gel, electrophoresed, and blotted onto a Hybond N
nylon membrane (GE Healthcare). Probes were generated
using exon specific primers (see Additional file 8) to amp-
lify day 0 cDNA and purified by 2 X 30 cycles of PCR.
50 ng of probe was labelled by random priming with α-
32-P dNTPs (Megaprime DNA labelling system,
GEHealthcare) and hybridized overnight at 65 °C in
Church and Gilbert solution. Membranes were washed for
10 min at room temperature in 2XSSC (3X) followed by
10 min at 65 °C in 1XSSC/0.1% SDS (2X), and 45 min at
65 °C in 0.1XSSC, 0.5% SDS. Membranes were exposed to
X-ray film with an intensifying screen at − 70 °C.
Amplicon sequencing of FIRRE transcripts
Exon-specific primers linked to Illumina sequencing
adapters were designed to generate amplicons spanning
potentially novel exons using cDNA from day 0 (see
Additional file 6). Primers were used in both convergent
and divergent orientation to enable amplification of both
circular and linear isoforms. Illumina sequencing indexes
were added to each amplicon using a Nextera indexing kit
(Illumina), and amplicons were sequenced to a target
depth of 1500-6000 reads (depending on the number and
intensity of visible products) using a MiSeq Nano Kit (Illu-
mina) all according to manufacturer’s recommendations.
Additional files
Additional file 1: Sequencing Quality Control. Data shows Illumina
quality control metrics. PF = Passing chastity filter. Q30 = Phred quality
score of 30 or above. (XLSX 9 kb)
Additional file 2: a-d. Gene Ontology analyses showing over and
under-represented gene ontologies (biological process and molecular
function) in genes differentially expressed between untreated time-
points. Analyses were performed using the Panther classification system
[73], with a Bonferroni correction for multiple testing. e. Genes differentially
expressed between IGF-1 treated and untreated samples. List includes
genes identified by comparision at each timepoint, and an all v all
comparison. No significant genes were identified in the day 90 analysis.
(XLSX 50 kb)
Additional file 3: Figure S1. Expression of genes implicated in
pluripotency, eye field formation, and circRNA biogenesis. Figure S2.
Intersection of structures identified by PTESFinder relative to other
commonly used circRNA identification methods. Figure S3. Heat map
showing genes differentially expressed between time-points and treatment.
Figure S4. ES cell specific circRNAs are low frequency structures derived
from highly expressed genes. Figure S5. Flow chart showing statistical
analysis of back-splice abundance. Figure S6. Relative expression of
canonical and back-splice junctions in DE genes. Figure S7. Identification
of abundant RMST and FIRRE back-splice junctions using other in silico
methods. Figure S8. Correlation between qPCR and RNAseq data.
Figure S9. Junction counts of major RMST and FIRRE circRNAs in
human embryonic / fetal samples. Figure S10. Additional circRNAs
defined by exons not present in FIRRE annotation and confirmation
of exon integration. Figure S11. The E10-E5 circRNA contains FIRRE
DDC repeats. Figure S12. Confirmation of RMST isoform differences
in independent adult datasets. (PDF 2416 kb)
Additional file 4: CircRNA transcripts showing significantly altered
expression in both locus and sample level analyses. Normalised circRNA
and canonical RNA junction read counts in all control sample replicates
are shown, together with average abundance ratio (circRNA junction
frequency/canonical junction frequency), genomic co-ordinates, and
circbase i.d.s where available. The most significant p-values obtained
in each group of pair-wise t-tests (sample DE and locus DE) are also
shown for each transcript. Analyses in which transcript was identified
are indicated as follows; U (untreated), I (IGF-1 treated), B (Both analyses). For
details of analysis, see text and methods. (XLSX 115 kb)
Additional file 5: Gene Ontology analysis showing over and under-
represented gene ontologies (biological process and molecular function)
in parent loci of 239 significantly altered circRNAs. Analyses were performed
using the Panther classification system [73], with a Bonferroni correction for
multiple testing. (XLSX 11 kb)
Additional file 6: FIRRE exon junctions confirmed by amplicon
sequencing. All reads were mapped against hg19 without reference to
transcript annotation: Amplicons using convergent primer pairs and
divergent primer pairs (to amplify circRNAs only) are shown separately.
Canonical junctions were mapped using MapSplice [67], circRNA (back-
splice) junctions were mapped using PTESFinder [46]. For details, see
methods. Exon number is according to schema in Fig. 6b. Junction
position (hg19), amplicons of origin, and junction frequencies, are given
for all junctions. Only splices with a frequency of 1% or higher in each
amplicon, identified either by MapSplice or PTESfinder, are reported.
Canonical junctions present within the current FIRRE annotation are show
in blue. All others are not present within current annotation. Off target
junctions (presumed to be generated by illegitimate primer binding) are
also shown. Data is for confirmation of junction presence within
transcripts only: Junction frequency is affected by position relative to
primer, size dependent amplification bias during Nextera indexing,
and size dependent bias in cluster formation/resolution efficiencies
during MiSeq sequencing. (XLSX 71 kb)
Additional file 7: Genomic co-ordinates of all annotated and novel
FIRRE exons. The position of all junctions are shown with respect to hg19,
together with their current annotations where appropriate. Splice acceptor
and donor junctions identified by annotation-free mapping of day 0
samples against hg19 using MapSplice are shown, together with
donor exons and acceptor exons, and junction numbers in brackets.
Supporting evidence for each junction is colour coded. Minor / Others –
additional junctions not involving annotated exons which are present at
low frequency. (XLSX 12 kb)
Additional file 8: Sequence of all primers generated for this study,
together with qPCR probes, amplification efficiencies, and primer/probe
combinations used. Exon content of amplicons used for Northern analyses
is also shown. For additional assays, see [7]. (XLSX 12 kb)
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